Genentech breaks ground on $750 million Hillsboro, Oregon manufacturing expansion

• Genentech, part of Roche, broke ground on a USD 750 million expansion of its Hillsboro, Oregon manufacturing site.
• Project adds 211,000 square feet, doubling the campus; commercial operations targeted to start in 2031.
• Expansion adds device fill-finish capacity for combination products, strengthening Genentech’s US supply chain for device-enabled medicines.
• Plan includes about 250 manufacturing jobs tied to AI, automation, robotics; construction expected to support about 200 jobs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via Business Wire (Ref. ID: 202609281800BIZWIRE_USPR_____20260928_BW061898) on September 28, 2026, and is solely responsible for the information contained therein.